Biogen
BIIB
BIIB
1,005 hedge funds and large institutions have $29.5B invested in Biogen in 2021 Q4 according to their latest regulatory filings, with 144 funds opening new positions, 293 increasing their positions, 394 reducing their positions, and 153 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
26% less repeat investments, than reductions
Existing positions increased: 293 | Existing positions reduced: 394
27% less funds holding in top 10
Funds holding in top 10: 15 → 11 (-4)
28% less call options, than puts
Call options by funds: $1.1B | Put options by funds: $1.52B
Holders
1,005
Holding in Top 10
11
Calls
$1.1B
Puts
$1.52B
Top Buyers
| 1 | +$206M | |
| 2 | +$166M | |
| 3 | +$146M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$139M |
| 5 |
Barclays
London,
United Kingdom
|
+$104M |
Top Sellers
| 1 | -$256M | |
| 2 | -$238M | |
| 3 | -$202M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$157M |
| 5 |
Primecap Management
Pasadena,
California
|
-$120M |